How ‘good’ bacteria from fecal transplants reduce peanut allergy
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Oct-2026 11:16 ET (28-Oct-2026 15:16 GMT/UTC)
Some 33 million Americans have severe food allergies. Now, researchers at Boston Children’s Hospital may have found a promising solution. In a small clinical trial, Rima Rachid, MD, director of the Food Allergy Program and the Allergen Immunotherapy Program, and Talal Chatila, MD, director of translational immunology, and their colleagues found that some participants with peanut allergies experienced a higher tolerance to peanuts months after receiving a fecal transplant from a healthy donor without food allergies. Their findings are published today in Science Translational Medicine.
With the support of National Institutes of Health funding, Johns Hopkins Medicine investigators, led by pathologist Aaron W. James, M.D., Ph.D., previously discovered that sensory neurons in skeletal tissue are constantly sensing their environment and are quick to respond to injuries. Through new research published in Science Translational Medicine, they describe how this response profoundly affects growth plates, the soft cartilage at the end of bones in children that support normal growth and development, and how it responds to targeted treatment in mice.
Following a growth plate injury, a rapid invasion of nerve fibers and blood vessels triggers the formation of an unwanted “bony bar,” a rigid bone-like structure that can ultimately impede recovery and lead to stunted or altered bone growth. Through this new research, the team found inhibiting TrkA+ sensory neurons with long-acting bupivacaine, an FDA-approved nerve-numbing anesthetic, reduced this abnormal growth by up to 60%.
When people encounter new information that challenges their expectations, their pupils are likely to dilate. This physiological response is a sign that something is happening in the brain to help the person adapt to the new situation, according to a study led by Brown University researchers and published in Nature Human Behaviour.
DepMap scientists have generated dependency data on nearly 150 three-dimensional cancer cell models across 10 cancer types.
The updated catalog reveals cancer phenotypes, cell states, and gene dependencies that are missed in traditional cell lines and shows that both model types are complementary because each captures biology that the other misses.
The integration of data on 2D and 3D models creates a more comprehensive DepMap, moving the resource towards its goal of capturing the complete landscape of cancer vulnerabilities.